Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Current Perspectives on the Lee Silverman Voice Treatment (LSVT) for Individuals With Idiopathic Parkinson Disease

Open access
Fox, Cynthia M., Morrison, Chris E., Ramig, Lorraine Olson, Sapir, Shimon·2002·American Journal of Speech-Language Pathology
DOI 10.1044/1058-0360(2002/012

Abstract

Open AccessAmerican Journal of Speech-Language PathologyViewpoint1 May 2002Current Perspectives on the Lee Silverman Voice Treatment (LSVT) for Individuals With Idiopathic Parkinson Disease Cynthia M. Fox, MA Chris E. Morrison, Lorraine Olson Ramig, and Shimon Sapir Cynthia M. Fox Contact author: Cynthia M. Fox, MA, Department of Speech and Hearing Sciences. PO Box 210071, University of Arizona, Tucson, AZ, 85721. E-mail: [email protected] University of Arizona, Tucson Google Scholar , Chris E. Morrison Mount Sinai Medical Center, New York, NY Google Scholar , Lorraine Olson Ramig University of Colorado, Boulder and Wilbur James Gould Voice Center, The Denver Center for the Performing Arts, Denver, CO Google Scholar and Shimon Sapir Wilbur James Gould Voice Center, The Denver Center for the Performing Arts, Denver, CO Google Scholar https://doi.org/10.1044/1058-0360(2002/012) SectionsAboutPDF ToolsAdd to favoritesDownload CitationTrack Citations ShareFacebookTwitterLinked In Successful treatment of speech disorders in individuals with progressive neuro logical diseases can be challenging. Hillman, Gress, Haugraf, Walsh, and Bunting (1990) stated that "voice treatment for disorders that are degenerative is controversial since there is no expectation for recovery of function or that any improvement secondary to speech language pathology intervention will be maintained in the long term" (p. 308). Individuals with idiopathic Parkinson disease (IPD) have been particularly resistant to speech treatment, with the conventional wisdom being summarized by the statement that changes observed in the treatment room disappear on the way to the parking lot (Allan, 1970; Aronson, 1985; Greene, 1980; Sarno, 1968; Weiner & Singer, 1989). The consensus that speech treatment has not been effective for individuals with IPD is, perhaps, the basis for the report that of the 75%–89% of these individuals with voice and speech disorders, only 3%–4% receive speech treatment (Hartelius & Svensson, 1994; Oxtoby, 1982). The reduced ability to communicate is considered to be one of the most difficult aspects of IPD by many patients and their families. Soft voice, monotone, breathy, hoarse voice quality, and imprecise articulation (Darley, Aronson, & Brown, 1969a, 1969b; Logemann, Fisher, Boshes, & Blonsky, 1978), together with lessened facial expression (masked facies), contribute to limitations in communication in the vast majority of individuals with IPD (Pitcairn, Clemie, Gray, & Pentland, 1990a, 1990b). Although medical treatments, including neuro-pharmacological as well as neurosurgical methods, may be effective in improving limb symptoms, their impact on speech production remains unclear (Baker, Ramig, Johnson, & Freed, 1997; Kompoliti, Wang, Goetz, Leurgans, & Raman, 2000; Larson, Ramig, & Scherer, 1994; Rigrodsky & Morrison, 1970; Solomon et al., 2000; Wang, Kompoliti, Jiang, & Goetz, 2000; Wolfe, Garvin, Bacon, & Waldrop, 1975). In addition, previous speech treatment for individuals with IPD, focusing on articulation and rate, has limited efficacy data and limited evidence of long-term success. Recently, there has been great progress in understanding the function of the basal ganglia; this has shed light on the neural bases of IPD (Albin, 1995; Brooks, 1995; Hayes, Davidson, Keele, & Rafal, 1998; Mink, 1996; Wichmann & DeLong, 1993, 1996). Although many studies have used these findings to understand limb function in individuals with IPD (Rand & Stelmach, 1999; Weiss, Stelmach, Chaiken, & Adler, 1999), their application to voice and speech disorders has been infrequent. At this time, the neural mechanisms underlying speech, voice, and swallowing disorders in IPD are not well understood. Over the past 10 years, our research team has focused on improving speech disorders in individuals with IPD by directing attention to phonation (voice) as a key treatment element. Although disordered voice has been observed in the majority of individuals with IPD (Logemann et al., 1978; Oxtoby, 1982; Streifler & Hofman, 1984), it has until recently been given limited attention in treatment and has been overlooked for its contribution to improving speech intelligibility. Treating voice in individuals with IPD has generated short- and long-term efficacy data for a speech treatment in this population (Ramig, Countryman, O'Brien, Hoehn, & Thompson, 1996; Ramig, Countryman, Thompson, & Horii, 1995; Ramig, Sapir, Countryman, Pawlas, O'Brien, Hoehn, & Thompson, 2001; Ramig, Sapir, Fox, & Countryman, 2001). This treatment—known as the Lee Silverman Voice Treatment (LSVT)—has as its essential concepts (a) exclusive focus on voice (specifically vocal loudness), (b) stimulation of high-effort productions with multiple repetitions, (c) intensive delivery of treatment (4 individual sessions a week for 4 weeks, 16 sessions in one month), (d) enhancing sensory awareness of increased vocal loudness and effort (calibration), and (e) quantification of behaviors (Ra

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1044/1058-0360(2002/012)

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 171

Metadata

Authors
Fox, C. M., Morrison, C. E., Ramig, L. O., & Sapir, S.
Venue
American Journal of Speech-Language Pathology
Published
2002-05
Volume
11
Issue
2
Pages
111-123
ISSN
  • 1058-0360 (ISSN-L)
  • 1558-9110
DOI
10.1044/1058-0360(2002/012
OpenAlex
W2002253940
Cited by
171
References
4
FWCI
3.31
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current Perspectives on the Lee Silverman Voice Treatment (LSVT) for Individuals With Idiopathic Parkinson Disease. https://app.cochat.ai/papers/10.1044/1058-0360(2002/012
The paper
Fox, C. M., Morrison, C. E., Ramig, L. O., & Sapir, S. (2002). Current Perspectives on the Lee Silverman Voice Treatment (LSVT) for Individuals With Idiopathic Parkinson Disease. American Journal of Speech-Language Pathology. https://doi.org/10.1044/1058-0360(2002/012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.